UroGen Pharma
(NASDAQ:URGN)
$8.46
At close: Jul 6
$8.88
0.4200[4.96%]
PreMarket: 5:51PM EDT
Day High/Low- - -
52 Week High/Low4.85 - 19.66
Open / Close- / -
Float / Outstanding17.7M / 22.7M
Vol / Avg.- / 201.6K
Mkt Cap192M
P/E-
50d Avg. Price6.62
Div / Yield-
Payout Ratio-
EPS-1.25
Total Float17.7M

UroGen Pharma (NASDAQ:URGN), Quotes and News Summary

UroGen Pharma (NASDAQ: URGN)

Day High/Low- - -
52 Week High/Low4.85 - 19.66
Open / Close- / -
Float / Outstanding17.7M / 22.7M
Vol / Avg.- / 201.6K
Mkt Cap192M
P/E-
50d Avg. Price6.62
Div / Yield-
Payout Ratio-
EPS-1.25
Total Float17.7M
Benzinga - Jun 8, 2022, 4:08AM
UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-1.330-1.250 0.0800
REV15.180M13.564M-1.616M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

UroGen Pharma Questions & Answers

Q
How do I buy UroGen Pharma (URGN) stock?
A

You can purchase shares of UroGen Pharma (NASDAQ: URGN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are UroGen Pharma's (URGN) competitors?
A

There are no as such competitors for UroGen Pharma.

Q
What is the target price for UroGen Pharma (URGN) stock?
A

The latest price target for UroGen Pharma (NASDAQ: URGN) was reported by Berenberg on Wednesday, April 27, 2022. The analyst firm set a price target for 20.00 expecting URGN to rise to within 12 months (a possible 136.41% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for UroGen Pharma (URGN)?
A

The stock price for UroGen Pharma (NASDAQ: URGN) is $8.46 last updated July 6, 2022, 8:00 PM UTC.

Q
Does UroGen Pharma (URGN) pay a dividend?
A

There are no upcoming dividends for UroGen Pharma.

Q
When is UroGen Pharma (NASDAQ:URGN) reporting earnings?
A

UroGen Pharma’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is UroGen Pharma (URGN) going to split?
A

There is no upcoming split for UroGen Pharma.

Q
What sector and industry does UroGen Pharma (URGN) operate in?
A

UroGen Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.